Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Here, we review the therapeutic effects of GLP-1 on depression from a variety of perspectives and highlight the promising, beneficial roles of GLP-1 as the therapeutic regulator of impaired neurogenesis, neuroinflammation, imbalance of neurotransmitter secretion, and synaptic dysfunction in the depressive brain
Hypromellose (cellulose capsule), microcrystalline cellulose, magnesium stearate (vegetable source) and silicon dioxide
This specific combination has not undergone the clinical trial process required for FDA approval
The results, which appear March 18 in BMJ Medicine, show that the consequences of stopping GLP-1 drugs go beyond weight regain, extending to increased cardiovascular risk, and underscore the importance of continuous treatment for sustained heart protection
It belongs to a class of drugs known as GLP-1 receptor agonists, but it goes further by also targeting GIP (glucose-dependent insulinotropic polypeptide) and glucagon receptors
Astrocytes, emerging stars of energy homeostasis
